198 related articles for article (PubMed ID: 2299641)
1. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
3. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.
Xiong WC; Nelson DL
Life Sci; 1989; 45(16):1433-42. PubMed ID: 2811600
[TBL] [Abstract][Full Text] [Related]
5. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
6. Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein.
Leonhardt S; Herrick-Davis K; Titeler M
J Neurochem; 1989 Aug; 53(2):465-71. PubMed ID: 2664084
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
9. Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region.
Glennon RA; Chaurasia C; Titeler M
J Med Chem; 1990 Oct; 33(10):2777-84. PubMed ID: 2213830
[TBL] [Abstract][Full Text] [Related]
10. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
Kaumann AJ; Frenken M; Posival H; Brown AM
Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes.
Heuring RE; Peroutka SJ
J Neurosci; 1987 Mar; 7(3):894-903. PubMed ID: 2951504
[TBL] [Abstract][Full Text] [Related]
12. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
Peroutka SJ
J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638
[TBL] [Abstract][Full Text] [Related]
14. [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.
Nowak HP; Mahle CD; Yocca FD
Br J Pharmacol; 1993 Aug; 109(4):1206-11. PubMed ID: 8401931
[TBL] [Abstract][Full Text] [Related]
15. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
[TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
18. Identification of serotonin receptors recognized by anti-idiotypic antibodies.
Tamir H; Liu KP; Hsiung SC; Yu PY; Kirchgessner AL; Gershon MD
J Neurochem; 1991 Sep; 57(3):930-42. PubMed ID: 1861158
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
Zemlan FP; Schwab EF
J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
[TBL] [Abstract][Full Text] [Related]
20. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Titeler M; Lyon RA; Glennon RA
Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
